130 related articles for article (PubMed ID: 37918543)
1. Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
Quadflieg K; Machado A; de Lima FF; Dederen A; Daenen M; Ruttens D; Thomeer M; Spruit MA; Burtin C
Respir Med; 2023 Dec; 220():107437. PubMed ID: 37918543
[TBL] [Abstract][Full Text] [Related]
2. Physical Tests Are Poorly Related to Patient-Reported Outcome Measures during Severe Acute Exacerbations of COPD.
Quadflieg K; Machado A; Haesevoets S; Daenen M; Thomeer M; Ruttens D; Spruit MA; Burtin C
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011892
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study.
Xu T; Sun W; Zhao H; Wang X; Yuan Q; Zhang X; Mao S; Zhang X; Zhao M; Sheng Z; Zhang M; Huang M; Ji N
Int J Chron Obstruct Pulmon Dis; 2022; 17():2329-2341. PubMed ID: 36164549
[TBL] [Abstract][Full Text] [Related]
4. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
5. Is the 6-minute pegboard and ring test valid to evaluate upper limb function in hospitalized patients with acute exacerbation of COPD?
Felisberto RM; de Barros CF; Nucci KCA; de Albuquerque ALP; Paulin E; de Brito CMM; Yamaguti WP
Int J Chron Obstruct Pulmon Dis; 2018; 13():1663-1673. PubMed ID: 29861629
[TBL] [Abstract][Full Text] [Related]
6. Respiratory and peripheral muscle strength influence recovery of exercise capacity after severe exacerbation of COPD? An observational prospective cohort study.
Heubel AD; Kabbach EZ; Leonardi NT; Schafauser NS; Kawakami DMO; Sentanin AC; Pires Di Lorenzo VA; Borghi Silva A; Hurst JR; Mendes RG
Heart Lung; 2023; 58():91-97. PubMed ID: 36434827
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD.
France G; Orme MW; Greening NJ; Steiner MC; Chaplin EJ; Clinch L; Singh SJ
Respir Med; 2021 Jan; 176():106249. PubMed ID: 33253973
[TBL] [Abstract][Full Text] [Related]
8. The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability.
Bernabeu-Mora R; Medina-Mirapeix F; Llamazares-Herrán E; García-Guillamón G; Giménez-Giménez LM; Sánchez-Nieto JM
Int J Chron Obstruct Pulmon Dis; 2015; 10():2619-26. PubMed ID: 26664110
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Home-Based Functional Status Assessment of Chronic Obstructive Pulmonary Disease Patients Recovering From an Exacerbation.
Valeiro B; Hernández C; Barberán-Garcia A; Rodríguez DA; Aibar J; Llop L; Vilaró J
Arch Bronconeumol; 2016 May; 52(5):256-61. PubMed ID: 26822266
[TBL] [Abstract][Full Text] [Related]
10. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
[TBL] [Abstract][Full Text] [Related]
11. Enhancing our understanding of the time course of acute exacerbations of COPD managed on an outpatient basis.
Oliveira A; Afreixo V; Marques A
Int J Chron Obstruct Pulmon Dis; 2018; 13():3759-3766. PubMed ID: 30538438
[TBL] [Abstract][Full Text] [Related]
12. Correlations Between Serum Decoy Receptor 3 and Airflow Limitation and Quality of Life in Male Patients with Stable Stage and Acute Exacerbation of COPD.
Ghobadi H; Hosseini N; Aslani MR
Lung; 2020 Jun; 198(3):515-523. PubMed ID: 32211977
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.
Fermont JM; Bolton CE; Fisk M; Mohan D; Macnee W; Cockcroft JR; McEniery C; Fuld J; Cheriyan J; Tal-Singer R; Wilkinson IB; Wood AM; Polkey MI; Müllerova H
PLoS One; 2020; 15(2):e0228940. PubMed ID: 32040531
[TBL] [Abstract][Full Text] [Related]
14. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing Activities of Daily Living in Subjects With COPD.
Ozsoy I; Ozcan Kahraman B; Acar S; Ozalevli S; Akkoclu A; Savci S
Respir Care; 2019 Feb; 64(2):189-195. PubMed ID: 30401755
[TBL] [Abstract][Full Text] [Related]
16. Examining changes in vascular function, arterial stiffness and systemic inflammation during hospitalization and recovery from an acute exacerbation of chronic obstructive pulmonary disease.
Fuhr DP; Brotto AR; Rowe BH; Bhutani M; Rosychuk RJ; Stickland MK
Sci Rep; 2023 Jul; 13(1):12245. PubMed ID: 37507427
[TBL] [Abstract][Full Text] [Related]
17. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
Gao W; Gao L; Yang F; Li Z
J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
[TBL] [Abstract][Full Text] [Related]
18. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
[TBL] [Abstract][Full Text] [Related]
19. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
Trials; 2012 Apr; 13():40. PubMed ID: 22520863
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines.
Wang C; Feng D; Dong S; He R; Fan B
J Clin Lab Anal; 2022 Mar; 36(3):e24204. PubMed ID: 35064606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
